Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.

Reprod Health · 2020 · PMC7275481 · PMID 32503556

Europe PMC DOI

hedged sentence

0.3500

closest p · 7.0× alpha

0.3500

boldest claim

The sentences

not significantly significantp = 0.35not close (p > 0.1)

More women in the placebo arm reported that they experienced fever; this difference was not significantly significant (7 (17.9%) vs. 4 (10%), p = 0.35).

also in 164 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.